Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- Check6 days agoChange DetectedThe page now indicates a newer ClinicalTrials.gov site revision (“v3.5.3”) instead of the previous one (“v3.5.0”). This reflects a site/software version update rather than any change to the clinical study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check57 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision label updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded a 'Show glossary' option to help users understand terms. The page now shows 'Last Update Submitted that Met QC Criteria' and a revision label 'Revision: v3.4.0', with minor wording refinements for FEAR Act data.SummaryDifference0.1%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.